Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis.
Clin Exp Rheumatol
; 33(4 Suppl 91): S31-5, 2015.
Article
in En
| MEDLINE
| ID: mdl-26314374
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Scleroderma, Systemic
/
Autoantibodies
/
DNA Topoisomerases, Type I
/
Polymorphism, Single Nucleotide
/
Receptors, CCR6
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Systematic_reviews
Limits:
Humans
Country/Region as subject:
America do norte
/
Europa
Language:
En
Journal:
Clin Exp Rheumatol
Year:
2015
Type:
Article
Affiliation country:
Spain